Analysis and Forecasts by Product & Services (Compound/Sample Management Products and Services); Sample Type (Chemical Compounds and Biosamples); Application (Drug Discovery, Gene Synthesis, Biobanking); End User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations (CROs), and Others) and Country.
No. of Pages:156
Report Code:
TIPRE00006670
Category:
Technology, Media and Telecommunications
The Asia Pacific compound management market is expected to reach US$ 167.94 Mn in 2027 from US$ 50.78 Mn in 2018. The market is estimated to grow with a CAGR of 14.9 % from 2019-2027.
The growth of the compound management market is driven by factors such as, rising drug discovery activity in the Asian countries and initiatives undertaken by the government bodies. However, market growth is likely to slow down due to shortage of skilled professionals in the region.
Asian countries, such as Korea, Japan, China, and Malaysia, among others, have been actively functioning in the biobanking sector. Biobanks in Korea operate in collaboration and are coordinated collectively by six government ministries. Human biobanks in Korea are administered by the Ministry of Food and Drug Safety; the Ministry of Science, ICT and Future Planning, and The Ministry of Health and Welfare. As per stats by Thermo Fisher, during 2016 Korea had more than 60 biobanks. In Japan, biobanks are managed by small laboratories that are present in academic or governmental institutes. However, recently, the Japanese government reorganized funding and management of biobanks to ensure quality management of biological resources. Moreover, the government is also strengthening its life science research by establishing a dedicated funding agency which provides strategic support for biobanks handling useful resources for industrialization.
Among the countries in the region, China is expected to lead the market during the forecast period. The growth of the market is primarily attributed to the established pharmaceutical market, increasing R&D expenditures by the pharmaceutical and biopharmaceutical companies, an increasing number of clinical trials due to lower cost, and favorable regulatory policies. China has the world’s second-largest pharmaceutical market. The excessive population in China, coupled with the rise of various communicable and non-communicable diseases, are majorly driving the growth of the pharmaceutical companies in China and making it a prime market in the Asia Pacific region.
China Compound Management Market Revenue and Forecasts to 2027 (US$ Mn)
ASIA PACIFIC COMPOUND MANAGEMENT – MARKET SEGMENTATION
By Product & Services
Compound/Sample Management Products
Instruments
Automated Compound/Sample Storage Systems
Manual Compound/Sample Storage Systems
Automated Liquid Handling Systems
Software
Services
By Sample Type
Chemical Compounds
Biosamples
By Application
Drug Discovery
Gene Synthesis
Biobanking
By End User
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Others
Company Profiles
Biosero Inc.
Meridian Bioscience
Evotec
Icagen, Inc.
TCG Lifesciences Pvt. Ltd.
TTP Labtech
Frontier Scientific Services
Hamilton Company
Tecan Trading AG
Brooks Life Sciences
Asia Pacific Compound Management Market Strategic Insights
Get more information on this report
Asia Pacific Compound Management Market Segmentation Analysis
Asia Pacific Compound Management Market Report Highlights
Asia Pacific Compound Management Report Scope
Report Attribute
Details
Market size in 2018
US$ 50.78 Million
Market Size by 2027
US$ 167.94 Million
CAGR (2019 - 2027)
14.9 %
Historical Data
2016-2017
Forecast period
2019-2027
Segments Covered
By Product & Services
Compound/Sample Management Products and Services
By Sample Type
Chemical Compounds and Biosamples
By Application
Drug Discovery
Gene Synthesis
Biobanking
By End User
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Research Organizations
Regions and Countries Covered
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Market leaders and key company profiles
Biosero Inc.
Meridian Bioscience
Evotec
Icagen, Inc.
TCG Lifesciences Pvt. Ltd.
TTP Labtech
Frontier Scientific Services
Hamilton Company
Tecan Trading AG
Brooks Life Sciences
Get more information on this report
Asia Pacific Compound Management Market Country and Regional Insights
Get more information on this report
Identical Market Reports with other Region/Countries
How big is the Asia Pacific Compound Management Market?
The Asia Pacific Compound Management Market is valued at US$ 50.78 Million in 2018, it is projected to reach US$ 167.94 Million by 2027.
What is the CAGR for Asia Pacific Compound Management Market by (2019 - 2027)?
As per our report Asia Pacific Compound Management Market, the market size is valued at US$ 50.78 Million in 2018, projecting it to reach US$ 167.94 Million by 2027. This translates to a CAGR of approximately 14.9 % during the forecast period.
What segments are covered in this report?
The Asia Pacific Compound Management Market report typically cover these key segments-
Product & Services (Compound/Sample Management Products and Services)
End User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations)
What is the historic period, base year, and forecast period taken for Asia Pacific Compound Management Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Compound Management Market report:
Historic Period : 2016-2017
Base Year : 2018
Forecast Period : 2019-2027
Who are the major players in Asia Pacific Compound Management Market?
The Asia Pacific Compound Management Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Biosero Inc.
Meridian Bioscience
Evotec
Icagen, Inc.
TCG Lifesciences Pvt. Ltd.
TTP Labtech
Frontier Scientific Services
Hamilton Company
Tecan Trading AG
Brooks Life Sciences
Who should buy this report?
The Asia Pacific Compound Management Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Asia Pacific Compound Management Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Asia Pacific Compound Management Market
